0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global RNAi-Based Biocontrol Products Market Research Report 2026
Published Date: 2026-03-18
|
Report Code: QYRE-Auto-34J19931
Home | Market Reports | Business & Industrial| Chemicals Industry
Global RNAi Based Biocontrol Products Market Research Report 2026
BUY CHAPTERS

Global RNAi-Based Biocontrol Products Market Research Report 2026

Code: QYRE-Auto-34J19931
Report
2026-03-18
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

RNAi-Based Biocontrol Products Market Size

The global RNAi-Based Biocontrol Products market was valued at US$ 137 million in 2025 and is anticipated to reach US$ 232 million by 2032, at a CAGR of 7.7% from 2026 to 2032.

RNAi-Based Biocontrol Products Market

RNAi-Based Biocontrol Products Market

RNAi-based biocontrol products are biological crop protection inputs that use RNA interference (RNAi) to silence essential genes in target pests or pathogens, thereby delivering control efficacy. Commercial formats include plant-incorporated protectants (PIP), where crops express specific RNA for in-plant protection, and non-PIP products, where dsRNA or short RNA actives are formulated for foliar spray and, in some cases, soil or chemigation delivery. Key upstream elements include nucleotide and enzyme or fermentation inputs for manufacturing (via in vitro transcription or fermentation-based expression), formulation carriers and adjuvant systems (encapsulation, controlled release, uptake enhancers, UV and rainfast stabilizers), QC analytics, packaging, and temperature-managed or ambient logistics solutions; cost and supply capability are mainly driven by scalable manufacturing, unit-cost reduction, and improved field stability. Major downstream customers include crop protection companies and formulators, seed companies for PIP pathways, large growers and grower groups, ag input distributors and retailers, and public programs in selected pest scenarios. Applications span broadacre crops, orchards, and protected horticulture, often positioned within IPM programs and resistance-management rotations. On an ex-works manufacturing basis, gross margins typically fall in the 30% to 50% range, shaped by production route, carrier system and QC standards, registered use patterns, and channel and service intensity; as scaling improves and manufacturing costs decline, margins may stabilize, while uncertainty remains around field delivery efficiency, persistence, and regulatory timelines.
The North American market for RNAi-Based Biocontrol Products is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for RNAi-Based Biocontrol Products is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for RNAi-Based Biocontrol Products in Farmland is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of RNAi-Based Biocontrol Products include Bayer, Corteva, Greenlight Biosciences, RNAissance Ag, Pebble Labs, Renaissance BioScience, Silicon Gene, Shanghai Plant Science Biotechnology, Xiaomo Biotech, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global RNAi-Based Biocontrol Products market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding RNAi-Based Biocontrol Products. The RNAi-Based Biocontrol Products market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global RNAi-Based Biocontrol Products market comprehensively. Regional market sizes by Type, by Application, by Target Organism, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist RNAi-Based Biocontrol Products manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of RNAi-Based Biocontrol Products Market Report

Report Metric Details
Report Name RNAi-Based Biocontrol Products Market
Accounted market size in 2025 US$ 137 million
Forecasted market size in 2032 US$ 232 million
CAGR 7.7%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • PIP
  • Non-PIP
Segment by Target Organism
  • Insect Pests
  • Nematodes and Mites
  • Pathogens
  • Other
Segment by Application
  • Farmland
  • Orchard
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer, Corteva, Greenlight Biosciences, RNAissance Ag, Pebble Labs, Renaissance BioScience, Silicon Gene, Shanghai Plant Science Biotechnology, Xiaomo Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Target Organism, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for RNAi-Based Biocontrol Products companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is RNAi-Based Biocontrol Products Market growing?

Ans: The RNAi-Based Biocontrol Products Market witnessing a CAGR of 7.7% during the forecast period 2026-2032.

What is the RNAi-Based Biocontrol Products Market size in 2032?

Ans: The RNAi-Based Biocontrol Products Market size in 2032 will be US$ 232 million.

Who are the main players in the RNAi-Based Biocontrol Products Market report?

Ans: The main players in the RNAi-Based Biocontrol Products Market are Bayer, Corteva, Greenlight Biosciences, RNAissance Ag, Pebble Labs, Renaissance BioScience, Silicon Gene, Shanghai Plant Science Biotechnology, Xiaomo Biotech

What are the Application segmentation covered in the RNAi-Based Biocontrol Products Market report?

Ans: The Applications covered in the RNAi-Based Biocontrol Products Market report are Farmland, Orchard, Other

What are the Type segmentation covered in the RNAi-Based Biocontrol Products Market report?

Ans: The Types covered in the RNAi-Based Biocontrol Products Market report are PIP, Non-PIP

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNAi-Based Biocontrol Products Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 PIP
1.2.3 Non-PIP
1.3 Market by Target Organism
1.3.1 Global RNAi-Based Biocontrol Products Market Size Growth Rate by Target Organism: 2021 vs 2025 vs 2032
1.3.2 Insect Pests
1.3.3 Nematodes and Mites
1.3.4 Pathogens
1.3.5 Other
1.4 Market by Application
1.4.1 Global RNAi-Based Biocontrol Products Market Growth by Application: 2021 vs 2025 vs 2032
1.4.2 Farmland
1.4.3 Orchard
1.4.4 Other
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global RNAi-Based Biocontrol Products Market Perspective (2021–2032)
2.2 Global RNAi-Based Biocontrol Products Growth Trends by Region
2.2.1 Global RNAi-Based Biocontrol Products Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 RNAi-Based Biocontrol Products Historic Market Size by Region (2021–2026)
2.2.3 RNAi-Based Biocontrol Products Forecasted Market Size by Region (2027–2032)
2.3 RNAi-Based Biocontrol Products Market Dynamics
2.3.1 RNAi-Based Biocontrol Products Industry Trends
2.3.2 RNAi-Based Biocontrol Products Market Drivers
2.3.3 RNAi-Based Biocontrol Products Market Challenges
2.3.4 RNAi-Based Biocontrol Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNAi-Based Biocontrol Products Players by Revenue
3.1.1 Global Top RNAi-Based Biocontrol Products Players by Revenue (2021–2026)
3.1.2 Global RNAi-Based Biocontrol Products Revenue Market Share by Players (2021–2026)
3.2 Global Top RNAi-Based Biocontrol Products Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by RNAi-Based Biocontrol Products Revenue
3.4 Global RNAi-Based Biocontrol Products Market Concentration Ratio
3.4.1 Global RNAi-Based Biocontrol Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNAi-Based Biocontrol Products Revenue in 2025
3.5 Global Key Players of RNAi-Based Biocontrol Products Head Offices and Areas Served
3.6 Global Key Players of RNAi-Based Biocontrol Products, Products and Applications
3.7 Global Key Players of RNAi-Based Biocontrol Products, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 RNAi-Based Biocontrol Products Breakdown Data by Type
4.1 Global RNAi-Based Biocontrol Products Historic Market Size by Type (2021–2026)
4.2 Global RNAi-Based Biocontrol Products Forecasted Market Size by Type (2027–2032)
5 RNAi-Based Biocontrol Products Breakdown Data by Application
5.1 Global RNAi-Based Biocontrol Products Historic Market Size by Application (2021–2026)
5.2 Global RNAi-Based Biocontrol Products Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America RNAi-Based Biocontrol Products Market Size (2021–2032)
6.2 North America RNAi-Based Biocontrol Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America RNAi-Based Biocontrol Products Market Size by Country (2021–2026)
6.4 North America RNAi-Based Biocontrol Products Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNAi-Based Biocontrol Products Market Size (2021–2032)
7.2 Europe RNAi-Based Biocontrol Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe RNAi-Based Biocontrol Products Market Size by Country (2021–2026)
7.4 Europe RNAi-Based Biocontrol Products Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific RNAi-Based Biocontrol Products Market Size (2021–2032)
8.2 Asia-Pacific RNAi-Based Biocontrol Products Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific RNAi-Based Biocontrol Products Market Size by Region (2021–2026)
8.4 Asia-Pacific RNAi-Based Biocontrol Products Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America RNAi-Based Biocontrol Products Market Size (2021–2032)
9.2 Latin America RNAi-Based Biocontrol Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America RNAi-Based Biocontrol Products Market Size by Country (2021–2026)
9.4 Latin America RNAi-Based Biocontrol Products Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNAi-Based Biocontrol Products Market Size (2021–2032)
10.2 Middle East & Africa RNAi-Based Biocontrol Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa RNAi-Based Biocontrol Products Market Size by Country (2021–2026)
10.4 Middle East & Africa RNAi-Based Biocontrol Products Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer RNAi-Based Biocontrol Products Introduction
11.1.4 Bayer Revenue in RNAi-Based Biocontrol Products Business (2021–2026)
11.1.5 Bayer Recent Development
11.2 Corteva
11.2.1 Corteva Company Details
11.2.2 Corteva Business Overview
11.2.3 Corteva RNAi-Based Biocontrol Products Introduction
11.2.4 Corteva Revenue in RNAi-Based Biocontrol Products Business (2021–2026)
11.2.5 Corteva Recent Development
11.3 Greenlight Biosciences
11.3.1 Greenlight Biosciences Company Details
11.3.2 Greenlight Biosciences Business Overview
11.3.3 Greenlight Biosciences RNAi-Based Biocontrol Products Introduction
11.3.4 Greenlight Biosciences Revenue in RNAi-Based Biocontrol Products Business (2021–2026)
11.3.5 Greenlight Biosciences Recent Development
11.4 RNAissance Ag
11.4.1 RNAissance Ag Company Details
11.4.2 RNAissance Ag Business Overview
11.4.3 RNAissance Ag RNAi-Based Biocontrol Products Introduction
11.4.4 RNAissance Ag Revenue in RNAi-Based Biocontrol Products Business (2021–2026)
11.4.5 RNAissance Ag Recent Development
11.5 Pebble Labs
11.5.1 Pebble Labs Company Details
11.5.2 Pebble Labs Business Overview
11.5.3 Pebble Labs RNAi-Based Biocontrol Products Introduction
11.5.4 Pebble Labs Revenue in RNAi-Based Biocontrol Products Business (2021–2026)
11.5.5 Pebble Labs Recent Development
11.6 Renaissance BioScience
11.6.1 Renaissance BioScience Company Details
11.6.2 Renaissance BioScience Business Overview
11.6.3 Renaissance BioScience RNAi-Based Biocontrol Products Introduction
11.6.4 Renaissance BioScience Revenue in RNAi-Based Biocontrol Products Business (2021–2026)
11.6.5 Renaissance BioScience Recent Development
11.7 Silicon Gene
11.7.1 Silicon Gene Company Details
11.7.2 Silicon Gene Business Overview
11.7.3 Silicon Gene RNAi-Based Biocontrol Products Introduction
11.7.4 Silicon Gene Revenue in RNAi-Based Biocontrol Products Business (2021–2026)
11.7.5 Silicon Gene Recent Development
11.8 Shanghai Plant Science Biotechnology
11.8.1 Shanghai Plant Science Biotechnology Company Details
11.8.2 Shanghai Plant Science Biotechnology Business Overview
11.8.3 Shanghai Plant Science Biotechnology RNAi-Based Biocontrol Products Introduction
11.8.4 Shanghai Plant Science Biotechnology Revenue in RNAi-Based Biocontrol Products Business (2021–2026)
11.8.5 Shanghai Plant Science Biotechnology Recent Development
11.9 Xiaomo Biotech
11.9.1 Xiaomo Biotech Company Details
11.9.2 Xiaomo Biotech Business Overview
11.9.3 Xiaomo Biotech RNAi-Based Biocontrol Products Introduction
11.9.4 Xiaomo Biotech Revenue in RNAi-Based Biocontrol Products Business (2021–2026)
11.9.5 Xiaomo Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global RNAi-Based Biocontrol Products Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of PIP
 Table 3. Key Players of Non-PIP
 Table 4. Global RNAi-Based Biocontrol Products Market Size Growth Rate by Target Organism (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Key Players of Insect Pests
 Table 6. Key Players of Nematodes and Mites
 Table 7. Key Players of Pathogens
 Table 8. Key Players of Other
 Table 9. Global RNAi-Based Biocontrol Products Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 10. Global RNAi-Based Biocontrol Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 11. Global RNAi-Based Biocontrol Products Market Size by Region (US$ Million), 2021–2026
 Table 12. Global RNAi-Based Biocontrol Products Market Share by Region (2021–2026)
 Table 13. Global RNAi-Based Biocontrol Products Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 14. Global RNAi-Based Biocontrol Products Market Share by Region (2027–2032)
 Table 15. RNAi-Based Biocontrol Products Market Trends
 Table 16. RNAi-Based Biocontrol Products Market Drivers
 Table 17. RNAi-Based Biocontrol Products Market Challenges
 Table 18. RNAi-Based Biocontrol Products Market Restraints
 Table 19. Global RNAi-Based Biocontrol Products Revenue by Players (US$ Million), 2021–2026
 Table 20. Global RNAi-Based Biocontrol Products Market Share by Players (2021–2026)
 Table 21. Global Top RNAi-Based Biocontrol Products Players by Tier (Tier 1, Tier 2, and Tier 3), based on RNAi-Based Biocontrol Products Revenue, 2025
 Table 22. Ranking of Global Top RNAi-Based Biocontrol Products Companies by Revenue (US$ Million) in 2025
 Table 23. Global 5 Largest Players Market Share by RNAi-Based Biocontrol Products Revenue (CR5 and HHI), 2021–2026
 Table 24. Global Key Players of RNAi-Based Biocontrol Products, Headquarters and Area Served
 Table 25. Global Key Players of RNAi-Based Biocontrol Products, Products and Applications
 Table 26. Global Key Players of RNAi-Based Biocontrol Products, Date of General Availability (GA)
 Table 27. Mergers and Acquisitions, Expansion Plans
 Table 28. Global RNAi-Based Biocontrol Products Market Size by Type (US$ Million), 2021–2026
 Table 29. Global RNAi-Based Biocontrol Products Revenue Market Share by Type (2021–2026)
 Table 30. Global RNAi-Based Biocontrol Products Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 31. Global RNAi-Based Biocontrol Products Revenue Market Share by Type (2027–2032)
 Table 32. Global RNAi-Based Biocontrol Products Market Size by Application (US$ Million), 2021–2026
 Table 33. Global RNAi-Based Biocontrol Products Revenue Market Share by Application (2021–2026)
 Table 34. Global RNAi-Based Biocontrol Products Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 35. Global RNAi-Based Biocontrol Products Revenue Market Share by Application (2027–2032)
 Table 36. North America RNAi-Based Biocontrol Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. North America RNAi-Based Biocontrol Products Market Size by Country (US$ Million), 2021–2026
 Table 38. North America RNAi-Based Biocontrol Products Market Size by Country (US$ Million), 2027–2032
 Table 39. Europe RNAi-Based Biocontrol Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Europe RNAi-Based Biocontrol Products Market Size by Country (US$ Million), 2021–2026
 Table 41. Europe RNAi-Based Biocontrol Products Market Size by Country (US$ Million), 2027–2032
 Table 42. Asia-Pacific RNAi-Based Biocontrol Products Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Asia-Pacific RNAi-Based Biocontrol Products Market Size by Region (US$ Million), 2021–2026
 Table 44. Asia-Pacific RNAi-Based Biocontrol Products Market Size by Region (US$ Million), 2027–2032
 Table 45. Latin America RNAi-Based Biocontrol Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Latin America RNAi-Based Biocontrol Products Market Size by Country (US$ Million), 2021–2026
 Table 47. Latin America RNAi-Based Biocontrol Products Market Size by Country (US$ Million), 2027–2032
 Table 48. Middle East & Africa RNAi-Based Biocontrol Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 49. Middle East & Africa RNAi-Based Biocontrol Products Market Size by Country (US$ Million), 2021–2026
 Table 50. Middle East & Africa RNAi-Based Biocontrol Products Market Size by Country (US$ Million), 2027–2032
 Table 51. Bayer Company Details
 Table 52. Bayer Business Overview
 Table 53. Bayer RNAi-Based Biocontrol Products Product
 Table 54. Bayer Revenue in RNAi-Based Biocontrol Products Business (US$ Million), 2021–2026
 Table 55. Bayer Recent Development
 Table 56. Corteva Company Details
 Table 57. Corteva Business Overview
 Table 58. Corteva RNAi-Based Biocontrol Products Product
 Table 59. Corteva Revenue in RNAi-Based Biocontrol Products Business (US$ Million), 2021–2026
 Table 60. Corteva Recent Development
 Table 61. Greenlight Biosciences Company Details
 Table 62. Greenlight Biosciences Business Overview
 Table 63. Greenlight Biosciences RNAi-Based Biocontrol Products Product
 Table 64. Greenlight Biosciences Revenue in RNAi-Based Biocontrol Products Business (US$ Million), 2021–2026
 Table 65. Greenlight Biosciences Recent Development
 Table 66. RNAissance Ag Company Details
 Table 67. RNAissance Ag Business Overview
 Table 68. RNAissance Ag RNAi-Based Biocontrol Products Product
 Table 69. RNAissance Ag Revenue in RNAi-Based Biocontrol Products Business (US$ Million), 2021–2026
 Table 70. RNAissance Ag Recent Development
 Table 71. Pebble Labs Company Details
 Table 72. Pebble Labs Business Overview
 Table 73. Pebble Labs RNAi-Based Biocontrol Products Product
 Table 74. Pebble Labs Revenue in RNAi-Based Biocontrol Products Business (US$ Million), 2021–2026
 Table 75. Pebble Labs Recent Development
 Table 76. Renaissance BioScience Company Details
 Table 77. Renaissance BioScience Business Overview
 Table 78. Renaissance BioScience RNAi-Based Biocontrol Products Product
 Table 79. Renaissance BioScience Revenue in RNAi-Based Biocontrol Products Business (US$ Million), 2021–2026
 Table 80. Renaissance BioScience Recent Development
 Table 81. Silicon Gene Company Details
 Table 82. Silicon Gene Business Overview
 Table 83. Silicon Gene RNAi-Based Biocontrol Products Product
 Table 84. Silicon Gene Revenue in RNAi-Based Biocontrol Products Business (US$ Million), 2021–2026
 Table 85. Silicon Gene Recent Development
 Table 86. Shanghai Plant Science Biotechnology Company Details
 Table 87. Shanghai Plant Science Biotechnology Business Overview
 Table 88. Shanghai Plant Science Biotechnology RNAi-Based Biocontrol Products Product
 Table 89. Shanghai Plant Science Biotechnology Revenue in RNAi-Based Biocontrol Products Business (US$ Million), 2021–2026
 Table 90. Shanghai Plant Science Biotechnology Recent Development
 Table 91. Xiaomo Biotech Company Details
 Table 92. Xiaomo Biotech Business Overview
 Table 93. Xiaomo Biotech RNAi-Based Biocontrol Products Product
 Table 94. Xiaomo Biotech Revenue in RNAi-Based Biocontrol Products Business (US$ Million), 2021–2026
 Table 95. Xiaomo Biotech Recent Development
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources
 Table 99. Authors List of This Report


List of Figures
 Figure 1. RNAi-Based Biocontrol Products Picture
 Figure 2. Global RNAi-Based Biocontrol Products Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global RNAi-Based Biocontrol Products Market Share by Type: 2025 vs 2032
 Figure 4. PIP Features
 Figure 5. Non-PIP Features
 Figure 6. Global RNAi-Based Biocontrol Products Market Size Comparison by Target Organism (US$ Million), 2021–2032
 Figure 7. Insect Pests Features
 Figure 8. Nematodes and Mites Features
 Figure 9. Pathogens Features
 Figure 10. Other Features
 Figure 11. Global RNAi-Based Biocontrol Products Market Size by Application (US$ Million), 2021–2032
 Figure 12. Global RNAi-Based Biocontrol Products Market Share by Application: 2025 vs 2032
 Figure 13. Farmland Case Studies
 Figure 14. Orchard Case Studies
 Figure 15. Other Case Studies
 Figure 16. RNAi-Based Biocontrol Products Report Years Considered
 Figure 17. Global RNAi-Based Biocontrol Products Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 18. Global RNAi-Based Biocontrol Products Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 19. Global RNAi-Based Biocontrol Products Market Share by Region: 2025 vs 2032
 Figure 20. Global RNAi-Based Biocontrol Products Market Share by Players in 2025
 Figure 21. Global RNAi-Based Biocontrol Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 22. The Top 10 and 5 Players Market Share by RNAi-Based Biocontrol Products Revenue in 2025
 Figure 23. North America RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. North America RNAi-Based Biocontrol Products Market Share by Country (2021–2032)
 Figure 25. United States RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Canada RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Europe RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Europe RNAi-Based Biocontrol Products Market Share by Country (2021–2032)
 Figure 29. Germany RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. France RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. U.K. RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Italy RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Russia RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Ireland RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Asia-Pacific RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Asia-Pacific RNAi-Based Biocontrol Products Market Share by Region (2021–2032)
 Figure 37. China RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Japan RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. South Korea RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Southeast Asia RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. India RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Australia & New Zealand RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Latin America RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Latin America RNAi-Based Biocontrol Products Market Share by Country (2021–2032)
 Figure 45. Mexico RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Brazil RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Middle East & Africa RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Middle East & Africa RNAi-Based Biocontrol Products Market Share by Country (2021–2032)
 Figure 49. Israel RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Saudi Arabia RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. UAE RNAi-Based Biocontrol Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. Bayer Revenue Growth Rate in RNAi-Based Biocontrol Products Business (2021–2026)
 Figure 53. Corteva Revenue Growth Rate in RNAi-Based Biocontrol Products Business (2021–2026)
 Figure 54. Greenlight Biosciences Revenue Growth Rate in RNAi-Based Biocontrol Products Business (2021–2026)
 Figure 55. RNAissance Ag Revenue Growth Rate in RNAi-Based Biocontrol Products Business (2021–2026)
 Figure 56. Pebble Labs Revenue Growth Rate in RNAi-Based Biocontrol Products Business (2021–2026)
 Figure 57. Renaissance BioScience Revenue Growth Rate in RNAi-Based Biocontrol Products Business (2021–2026)
 Figure 58. Silicon Gene Revenue Growth Rate in RNAi-Based Biocontrol Products Business (2021–2026)
 Figure 59. Shanghai Plant Science Biotechnology Revenue Growth Rate in RNAi-Based Biocontrol Products Business (2021–2026)
 Figure 60. Xiaomo Biotech Revenue Growth Rate in RNAi-Based Biocontrol Products Business (2021–2026)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS